Oculo-gastrointestinal muscular dystrophy
Oculo-Gastrointestinal Muscular Dystrophy (OGMD) is a rare genetic disorder characterized by a combination of ocular (eye-related) and gastrointestinal symptoms due to muscular dystrophy. This condition is part of a group of diseases known as mitochondrial myopathies, which affect the mitochondria—the parts of the cell that produce energy. OGMD is notable for its impact on the muscles controlling the eyes and digestive system, leading to specific symptoms related to these areas.
Symptoms[edit]
The primary symptoms of OGMD involve the eyes and the gastrointestinal system. Ocular symptoms can include ptosis (drooping of the upper eyelid), ophthalmoplegia (paralysis or weakness of the eye muscles), and difficulties with eye movement. Gastrointestinal symptoms may encompass a range of issues such as dysphagia (difficulty swallowing), gastroparesis (delayed stomach emptying), and general gastrointestinal motility disorders, which can lead to malnutrition and weight loss.
Causes[edit]
OGMD is caused by mutations in genes responsible for the proper function of mitochondria. Since mitochondria are crucial for energy production in cells, mutations can lead to a decrease in energy available for muscle function, particularly in muscles that require a high amount of energy, such as those controlling the eyes and digestive system. The inheritance pattern of OGMD can be either autosomal dominant, autosomal recessive, or mitochondrial inheritance (also known as maternal inheritance), depending on the specific gene mutation involved.
Diagnosis[edit]
Diagnosis of OGMD involves a combination of clinical evaluation, family history, and genetic testing. Ophthalmologic and gastrointestinal examinations are crucial for identifying the characteristic symptoms of the disease. Muscle biopsy and electromyography (EMG) may also be used to assess muscle function and structure. Genetic testing can confirm the diagnosis by identifying the specific mutation causing the disorder.
Treatment[edit]
There is currently no cure for OGMD, and treatment focuses on managing symptoms and improving quality of life. Ocular symptoms may be treated with surgeries such as ptosis repair or interventions to improve eye muscle function. Gastrointestinal symptoms are managed through dietary modifications, medications to improve gastrointestinal motility, and, in severe cases, feeding tubes or parenteral nutrition. Regular follow-up with specialists in neurology, ophthalmology, and gastroenterology is essential for optimal management of the condition.
Prognosis[edit]
The prognosis for individuals with OGMD varies depending on the severity of symptoms and the effectiveness of symptom management strategies. While the condition can significantly impact quality of life, with appropriate care, many individuals can lead active and fulfilling lives.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
